Antibodies that bind glucosaminidase and uses thereof
Номер патента: EP4291576A1
Опубликовано: 20-12-2023
Автор(ы): Mark BENEDYK
Принадлежит: Telephus Biosciences LLC
Опубликовано: 20-12-2023
Автор(ы): Mark BENEDYK
Принадлежит: Telephus Biosciences LLC
Реферат: This disclosure provides glucosaminidase (Gmd)-binding antibodies capable of inhibiting growth of Staphylococcus and methods of making and using these antibodies in for example, diagnostic prognostic methods, and therapeutic applications. The disclosure further provides methods for treating a Staphylococcus (e.g., S. aureus) infection using the Gmd-binding antibodies. Methods for treating conditions associated with microbial infections incuding for example, fever, bacteremia, endocarditis, osteomyelitis, pneumonia, sepsis, septic shock, dermonecrosis, and mastitis are also provided.
BINDING MOLECULES THAT BIND HUMAN COMPLEMENT FACTOR C2 AND USES THEREOF
Номер патента: US20180319895A1. Автор: Simons Petrus Johannes,Boon Louis,HACK CORNELIS ERIK,YILDIZ CAFER. Владелец: . Дата публикации: 2018-11-08.